Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Gaye Hafez

Showing results (11-20 of 27) with videos related to

Pageof 3
Sort By:
Clinical Kidney Journal|December 4, 2023
Drugs with a negative impact on cognitive function (Part 1): chronic kidney disease as a risk factorSophie Liabeuf, Vesna Pešić, Goce Spasovski, et al.
Nephrology, Dialysis, Transplantation : Official Publication of the European Dialysis and Transplant Association - European Renal Association|March 13, 2025
Genetic and circulating biomarkers of cognitive dysfunction and dementia in CKDCarmine Zoccali, Francesca Mallamaci, Carsten A Wagner, et al.
Journal of General Internal Medicine|June 28, 2024
Barriers and Unmet Educational Needs Regarding Implementation of Medication Adherence Management Across Europe: Insights from COST Action ENABLEGaye Hafez, Emma Aarnio, Sara Mucherino, et al.
British Journal of Clinical Pharmacology|July 29, 2024
Pan-European survey on medication adherence management by healthcare professionalsMaria Kamusheva, Emma Aarnio, Miriam Qvarnström, et al.
Nephrology, Dialysis, Transplantation : Official Publication of the European Dialysis and Transplant Association - European Renal Association|February 7, 2025
Cholinergic system in patients with chronic kidney disease: cognitive and renal implicationsHong Xu, Maria Eriksdotter, Gaye Hafez, et al.
Nephrology, Dialysis, Transplantation : Official Publication of the European Dialysis and Transplant Association - European Renal Association|November 5, 2021
Albuminuria as a risk factor for mild cognitive impairment and dementia-what is the evidence?Boris Bikbov, Maria José Soler, Vesna Pešić, et al.
Frontiers in Medicine|August 25, 2023
Methodological challenges and biases in the field of cognitive function among patients with chronic kidney diseaseKonstantinos Giannakou, Aleksandra Golenia, Sophie Liabeuf, et al.
BMC Medical Education|March 5, 2025
Medication adherence in the curricula of future European physicians, pharmacists and nurses - a cross-sectional surveyHanna Gottlieb, Laura Seghers, Francisca Leiva-Fernandez, et al.
Clinical Kidney Journal|December 4, 2023
Drugs with a negative impact on cognitive functions (Part 2): drug classes to consider while prescribing in CKD patientsGaye Hafez, Jolanta Malyszko, Aleksandra Golenia, et al.
Nephrology, Dialysis, Transplantation : Official Publication of the European Dialysis and Transplant Association - European Renal Association|October 31, 2021
Acidosis, cognitive dysfunction and motor impairments in patients with kidney diseasePedro H Imenez Silva, Robert Unwin, Ewout J Hoorn, et al.
Pageof 3

Showing results (11-20 of 27) with videos related to

Sort By:
Pageof 3
Clinical Kidney Journal|December 4, 2023
Drugs with a negative impact on cognitive function (Part 1): chronic kidney disease as a risk factorSophie Liabeuf, Vesna Pešić, Goce Spasovski, et al.
Nephrology, Dialysis, Transplantation : Official Publication of the European Dialysis and Transplant Association - European Renal Association|March 13, 2025
Genetic and circulating biomarkers of cognitive dysfunction and dementia in CKDCarmine Zoccali, Francesca Mallamaci, Carsten A Wagner, et al.
Journal of General Internal Medicine|June 28, 2024
Barriers and Unmet Educational Needs Regarding Implementation of Medication Adherence Management Across Europe: Insights from COST Action ENABLEGaye Hafez, Emma Aarnio, Sara Mucherino, et al.
British Journal of Clinical Pharmacology|July 29, 2024
Pan-European survey on medication adherence management by healthcare professionalsMaria Kamusheva, Emma Aarnio, Miriam Qvarnström, et al.
Nephrology, Dialysis, Transplantation : Official Publication of the European Dialysis and Transplant Association - European Renal Association|February 7, 2025
Cholinergic system in patients with chronic kidney disease: cognitive and renal implicationsHong Xu, Maria Eriksdotter, Gaye Hafez, et al.
Nephrology, Dialysis, Transplantation : Official Publication of the European Dialysis and Transplant Association - European Renal Association|November 5, 2021
Albuminuria as a risk factor for mild cognitive impairment and dementia-what is the evidence?Boris Bikbov, Maria José Soler, Vesna Pešić, et al.
Frontiers in Medicine|August 25, 2023
Methodological challenges and biases in the field of cognitive function among patients with chronic kidney diseaseKonstantinos Giannakou, Aleksandra Golenia, Sophie Liabeuf, et al.
BMC Medical Education|March 5, 2025
Medication adherence in the curricula of future European physicians, pharmacists and nurses - a cross-sectional surveyHanna Gottlieb, Laura Seghers, Francisca Leiva-Fernandez, et al.
Clinical Kidney Journal|December 4, 2023
Drugs with a negative impact on cognitive functions (Part 2): drug classes to consider while prescribing in CKD patientsGaye Hafez, Jolanta Malyszko, Aleksandra Golenia, et al.
Nephrology, Dialysis, Transplantation : Official Publication of the European Dialysis and Transplant Association - European Renal Association|October 31, 2021
Acidosis, cognitive dysfunction and motor impairments in patients with kidney diseasePedro H Imenez Silva, Robert Unwin, Ewout J Hoorn, et al.
Pageof 3